Evidence map›Paper›PMID 41486569›Full record

ArticleCell biochemistry and function2026

Morphological and Optical Characterization of NRAS-Mutant Melanoma Cells and Primary Melanocytes via Quantitative Phase Imaging With Digital Holographic Microscopy.

Ayah A Farhat, Yazan A Almahdi, Fatima Z Alshuhani, Besa Xhabija

Abstract read
In one paragraph

Article in Cell biochemistry and function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ayah A FarhatDepartment of Natural Science, College of Arts, Sciences and Letters, University of Michigan-Dearborn, Dearborn, Michigan, USA.
Yazan A AlmahdiDepartment of Natural Science, College of Arts, Sciences and Letters, University of Michigan-Dearborn, Dearborn, Michigan, USA.
Fatima Z AlshuhaniDepartment of Natural Science, College of Arts, Sciences and Letters, University of Michigan-Dearborn, Dearborn, Michigan, USA.
Besa XhabijaDepartment of Natural Science, College of Arts, Sciences and Letters, University of Michigan-Dearborn, Dearborn, Michigan, USA.

Funding

University of Michigan-Dearborn
6 · The paper itself

Abstract

Early detection of melanoma, a highly variable and aggressive form of skin cancer, is crucial for improving patient outcomes. It is essential to distinguish malignant cells from normal melanocytes, and therefore, label-free imaging methods that can do so are needed. Given the genotoxic effect of UV radiation, these mutations are numerous and affect many genes, including NRAS; therefore, therapeutic strategies can be directed toward these recurrent mutations. The aggressive nature of NRAS-mutant melanoma contributes to poor patient prognosis, highlighting the need for early diagnosis. This study utilizes quantitative phase imaging (QPI) with digital holographic microscopy (DHM) to differentiate the morphology of NRAS-mutant SK-MEL-2 cells from melanocytes using holographic microscopy; dimensionality reduction techniques, including Principal Component Analysis (PCA),t-distributed stochastic neighbor embedding (t-SNE); and clustering techniques, including K-Means Elbow Plots and Hierarchical Clustering Dendrograms. The results demonstrated distinct morphologies and geometries between melanocytes and SK-MEL-2 cells, indicating that QPI with DHM can serve as a label-free tool for identifying optical biomarkers in melanoma.

Indexed as

GTP PhosphohydrolasesHolographyMelanocytesMelanomaMembrane ProteinsMicroscopyMutationSkin NeoplasmsCell Line, TumorHumansQuantitative Phase ImagingGTP PhosphohydrolasesMembrane ProteinsNRAS protein, humancell morphologyclusteringholographic microscopymelanocytesmelanomaNRAS mutationoptical parametersPCASK‐MEL‐2t‐SNE

Identifiers

PMID41486569
PMCPMC12766061

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.